This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Anthem (ANTM) Grows on Membership, Rising Expenses Hurt
by Zacks Equity Research
Anthem's (ANTM) revenues gain from solid membership base and rising net investment income. However, public exchange loss and rising expenses continue to bother.
The Zacks Analyst Blog Highlights: TOTAL S.A., Humana, Novo Nordisk, Target and Xcel
by Zacks Equity Research
The Zacks Analyst Blog Highlights: TOTAL S.A., Humana, Novo Nordisk, Target and Xcel
Ensign Group (ENSG) Q3 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) earnings missed estimates in Q3 but grew year over year due to higher revenues.
Humana (HUM) Beats Q3 Earnings Estimates, Revenues Miss
by Zacks Equity Research
Humana's (HUM) strong third-quarter earnings were driven by significantly low share count.
Humana's (HUM) Q3 Earnings Beat, Revenues Miss
by Anupama Mukhopadhyay
Humana's (HUM) third quarter earnings beat estimates but revenues miss expectations.
Can Retail Segment Further Drive Humana's (HUM) Q3 Earnings?
by Zacks Equity Research
Humana's (HUM) third-quarter results are likely to be driven by strong performance of its Retail segment.
Cigna (CI) Q3 Earnings Beat on Higher Enrollment, Guides Up
by Zacks Equity Research
Cigna's (CI) strong third-quarter earnings were driven by broad-based growth across its business segments.
Will Increased Visits Drive Teladoc's (TDOC) Q3 Earnings?
by Zacks Equity Research
Teladoc's (TDOC) earnings will benefit from its premier consumer engagement capabilities, broad network and scalable platform, which will increase visits and clients.
Will High Costs Dent Envision Healthcare (EVHC) Q3 Earnings?
by Zacks Equity Research
Envision Healthcare's (EVHC) third-quarter earnings are likely to see a drag from high expenses, partly offset by increased revenues from its physician services segment.
Will Lower Health Care Revenues Mar Aetna (AET) Q3 Earnings?
by Zacks Equity Research
Aetna's (AET) third-quarter earnings are likely see a drain from lesser membership and low revenues in the Health Care segment, partly offset by benefits from share buyback and cost control.
Will Higher Admissions Aid HCA Healthcare (HCA) Q3 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter earnings are likely to be benefited by its inorganic growth measures partly offset by industry weakness.
Can Admissions Rise Fuel Universal Health (UHS) Q3 Earnings?
by Zacks Equity Research
Universal Health's (UHS) third-quarter results are likely to be driven by solid revenue growth in both its Acute Care and Behavioral Health segments.
Can Enrollment Growth Drive Anthem (ANTM) in Q3 Earnings?
by Zacks Equity Research
Anthem's (ANTM) third-quarter results are likely to be aided by membership growth.
Will CNC Q3 Earnings Come in Better Than ESRX on Oct 24?
by Zacks Equity Research
Centene (CNC) is expected to post better results in Q3 compared to Express Scripts (ESRX) on the back of solid revenue growth driven by rising membership.
Can Medicaid Business Drive Centene's (CNC) Q3 Earnings?
by Zacks Equity Research
Centene's (CNC) third-quarter results are expected to be positively impacted by its Medicaid expansion initiatives.
Humana Expands MA Offerings, Increases Benefits for Members
by Zacks Equity Research
Humana (HUM) continues to expand and restructure its Medicare Advantage plans in order to enhance the reach and quality of its offerings across the world.
UnitedHealth (UNH) Beats Q3 Earnings on Higher Membership
by Zacks Equity Research
UnitedHealth (UNH) beats earnings in the third quarter driven by higher contribution from both its segments.
WellCare (WCG) Unit Receives Favorable Star Ratings From CMS
by Zacks Equity Research
WellCare's (WCG) efforts to boost its Medicare business and provide its Medicare Advantage members quality services have helped it achieve favorable Star Quality ratings from CMS
Will Quest Diagnostics (DGX) Disappoint in Q3 Earnings?
by Zacks Equity Research
The overall soft industry trends leading to low volume environment may continue to put a dampener on Quest Diagnostics (DGX) in Q3. The reimbursement scenario also remains a major cause for concern.
Buy These 4 Momentum Stocks for Exciting Returns
by Zacks Equity Research
This screen will help you to get into momentum stocks that are storming ahead. Highlighted stocks include HUM, JBL, GBX and AMTD.
Anthem (ANTM) & Units Receive Medicare Star Ratings From CMS
by Zacks Equity Research
Anthem's (ANTM) focus on improving the quality of healthcare for its Medicare Advantage members has enabled it achieve favorable Star Ratings from CMS
UnitedHealth (UNH) Q3 Earnings Likely to Beat: Here's Why?
by Zacks Equity Research
UnitedHealth's (UNH) third-quarter earnings are expected to benefit from strong contribution from both its segments along earnings accretion from disciplined capital management.
Molina Healthcare Appoints CEO: Will New Leadership Help?
by Zacks Equity Research
Molina Healthcare (MOH) appoints new CEO in an attempt to regain its lost glory.
WellCare Health Grows on Revenues, Debt Level Hurts
by Zacks Equity Research
Wellcare Health's (WCG) revenues continue to grow on the back of several organic and inorganic growth strategies. However, rising level of debt and expenses keep draining the bottom line.
Humana Partners With Community Care, Improves Healthcare
by Zacks Equity Research
Humana (HUM) builds strategic alliances in order to expand its geographical presence and ensure premium quality of healthcare by strengthening its value proposition.